Rachel A. Freedman

Breast cancer statistics 2024

Angela N. Giaquinto, Hyuna Sung, Lisa A. Newman et al. · CA A Cancer Journal for Clinicians · 2024 · 645 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

Rachel A. Freedman, Rebecca Gelman, Carey K. Anders et al. · Journal of Clinical Oncology · 2019 · 338 citations · Full text

Medicine, Oncology, Pharmacology +17

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer

Stephanie M. Wong, Rachel A. Freedman, Yasuaki Sagara et al. · Annals of Surgery · 2016 · 301 citations

Medicine, Oncology, Surgery +13

HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers

Bob T. Li, Flavia Michelini, Sandra Misale et al. · Cancer Discovery · 2020 · 289 citations · Full text

Medicine, Oncology, Pharmacology +17

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care

Rachel A. Freedman, Katherine S. Virgo, Yulei He et al. · Cancer · 2010 · 203 citations · Full text

Public Health, Oncology, Cancer Epidemiology +16